Navigation Links
Inaccurate diagnoses of melanoma by smartphone apps could delay doctor visits, life-saving treatment
Date:1/16/2013

PITTSBURGH, Jan. 16, 2013 Smartphone applications that claim to evaluate a user's photographs of skin lesions for the likelihood of cancer instead returned highly variable and often inaccurate feedback, according to a study led by researchers at the University of Pittsburgh School of Medicine. The findings, published in JAMA Dermatology and available online today, suggest that relying on these "apps" instead of consulting with a physician may delay the diagnosis of melanoma and timely, life-saving treatment.

"Smartphone usage is rapidly increasing, and the applications available to consumers have moved beyond communication and entertainment to everything under the sun, including health care," said lead researcher Laura Ferris, M.D., Ph.D., assistant professor, Department of Dermatology, University of Pittsburgh School of Medicine. "These tools may help patients be more mindful about their health care and improve communication between themselves and their physicians, but it's important that users don't allow their 'apps' to take the place of medical advice and physician diagnosis."

In fact, the study found that three out of the four smartphone applications tested incorrectly diagnosed 30 percent or more melanomas as "unconcerning" based on their evaluation of user images.

The study, funded by the National Institutes of Health (NIH) and the University of Pittsburgh Clinical and Translational Science Institute, reviewed applications available in the two most popular smartphone platforms and found that such tools often are marketed to nonclinical users to help them decide, using a digital image for analysis, whether or not their skin lesions are potential melanomas or otherwise concerning, or if they likely are benign. Researchers uploaded 188 images of skin lesions to each of the four applications, which then analyzed the images in different ways, including automated algorithms and images reviewed by an anonymous board-certified dermatologist. The applications often are available for free or at a very low cost, and are not subject to any regulatory oversight or validation.

Only the application that utilized dermatologists for a personal review of user images, essentially functioning as a tool to facilitate teledermatology, provided a high degree of sensitivity in diagnosis - just one of the 53 melanomas was diagnosed as "benign" by the experts reading the images. This application also was the most expensive, costing users $5 per image evaluation. Although the tools included disclaimers stating they were providing information for educational purposes only, researchers noted the risk that patients might rely on the application's evaluation rather than seek the advice of a medical professional.

The likelihood of relying on the application's free or low-cost evaluation is particularly concerning for the uninsured or economically disadvantaged, especially because a substantial number of melanomas are first detected by patients, noted the study authors. "If they see a concerning lesion but the smartphone app incorrectly judges it to be benign, they may not follow up with a physician," said Dr. Ferris. "Technologies that decrease the mortality rate by improving self- and early-detection of melanomas would be a welcome addition to dermatology. But we have to make sure patients aren't being harmed by tools that deliver inaccurate results."


'/>"/>

Contact: Carrie Stevenson
BeckerC@upmc.edu
412-586-9778
University of Pittsburgh Schools of the Health Sciences
Source:Eurekalert

Related medicine news :

1. Websites Touting Designer Vagina Surgeries Often Inaccurate, Study Finds
2. All-they-can-eat diet for lab mice and rats may foster inaccurate test results
3. 2 new vitamin D blood tests are often highly inaccurate, researchers say
4. Electronic visits offer accurate diagnoses, may lead to overprescribing of antibiotics
5. UMass Amherst chemists develop nose-like sensor array to smell cancer diagnoses
6. Missed Diagnoses in ICU Often Have Deadly Results: Review
7. Johns Hopkins team finds ICU misdiagnoses may account for as many annual deaths as breast cancer
8. Dr. Davis Announces Some Diagnoses of ADHD May be Misinterpreted Visual Problems: Could Be Treated with Vision Therapy
9. Drug-resistant melanoma tumors shrink when therapy is interrupted
10. Indication of considerable added benefit of vemurafenib in advanced melanoma
11. New screening approach identified potential drug combos for difficult-to-treat melanomas
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/12/2017)... ... October 12, 2017 , ... Leading pediatric oncology experts at ... for the 49th Congress of the International Society of Paediatric Oncology (SIOP) ... Center for Cancer and Blood Disorders at Children’s National, and Stephen P. ...
(Date:10/12/2017)... GRAND RAPIDS, Mich. (PRWEB) , ... October 12, ... ... OnSite Wellness, has been named one of Michigan’s 2017 Best and Brightest in ... Best and Brightest in Wellness® awards program on Friday, Oct. 20 from 7:30 ...
(Date:10/12/2017)... ... October 12, 2017 , ... In the United States, single-family ... some states—like New York, New Jersey, Massachusetts, Texas, Virginia, Connecticut, and California—the average ... extremely low property-tax rates, which contributes to the relatively lower cost of living ...
(Date:10/12/2017)... ... October 12, 2017 , ... ... University of California Berkeley, and other leading institutions in announcing the launch of ... institutions to change the way animals are raised for food. , Founding members ...
(Date:10/12/2017)... , ... October 12, 2017 , ... ... manufacturer, has expanded its executive staff with the addition of industry sales leader, ... role, Slott will develop the national distribution and sales network, direct the efforts ...
Breaking Medicine News(10 mins):
(Date:10/2/2017)... Fla. , Oct. 2, 2017  AllianceRx Walgreens ... company formed by Walgreens and pharmacy benefit manager Prime ... its new brand, which included the unveiling of new ... , as well as at a few other ... the new brand to patients, some of whom will ...
(Date:9/28/2017)... 28, 2017 Cohen Veterans Bioscience and Early ... of wearable and home sensors for real-time monitoring of ... Foundation, a nonprofit organization focused on disruptive health solutions ... affordable analytical system to record and integrate behavioral, cognitive, ... ...
(Date:9/25/2017)... 2017  EpiVax, Inc., a leader in the ... today announced the launch of EpiVax Oncology Inc., ... therapeutic cancer vaccines. EpiVax has provided $500,000 in ... enabling technologies to the new precision immunotherapy venture. ... Oncology as Chief Executive Officer. Gad brings over ...
Breaking Medicine Technology: